{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:12:44Z","timestamp":1791335564680,"version":"4.3.1"},"reference-count":73,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Vulvovaginal atrophy, characterized by the thinning of vaginal mucosa typically resulting from reduced estrogen levels, is frequently exacerbated by oncogynecologic treatments such as chemotherapy, hormonal therapy, radiotherapy, or surgery. This condition significantly impacts the quality of life for cancer survivors, leading to persistent discomfort, heightened infection risk, and negative effects on sexual function and self-esteem. Despite being a relatively common complication, vulvovaginal atrophy is not always discussed before the start of treatment. Treatments typically mirror those used for natural menopause; however, efficacy and safety data specific to this population are limited due to the exclusion of these patients from clinical trials. A major safety concern is the risk of hormone-sensitive cancer recurrence associated with estrogen therapy, which drives a preference for non-hormonal alternatives. Newer treatments, such as laser therapy, radiofrequency, and vaginal injections, show promise with minimal side effects and hormone-independent mechanisms, though efficacy data varies, highlighting the need for further research. This narrative review explores the epidemiology, risk factors, diagnosis, and management of vulvovaginal atrophy after the treatment for oncogynecologic disorders.<\/jats:p>","DOI":"10.3390\/medicina60101584","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T03:44:13Z","timestamp":1727408653000},"page":"1584","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Vulvovaginal Atrophy Following Treatment for Oncogynecologic Pathologies: Etiology, Epidemiology, Diagnosis, and Treatment Options"],"prefix":"10.3390","volume":"60","author":[{"given":"Ramun\u0117","family":"Narutyt\u0117","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Vilnius University, LT-03101 Vilnius, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoda","family":"\u017dukien\u0117","sequence":"additional","affiliation":[{"name":"Clinic of Obstetrics and Gynaecology, Faculty of Medicine, Institute of Clinical Medicine, Vilnius University, LT-03101 Vilnius, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiva","family":"Bartkevi\u010dien\u0117","sequence":"additional","affiliation":[{"name":"Clinic of Obstetrics and Gynaecology, Faculty of Medicine, Institute of Clinical Medicine, Vilnius University, LT-03101 Vilnius, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"key":"ref_1","unstructured":"Bleibel, B., and Nguyen, H. (2023). Vaginal Atrophy. StatPearls, StatPearls Publishing."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.clbc.2017.05.008","article-title":"Vaginal Atrophy in Breast Cancer Survivors: Attitude and Approaches among Oncologists","volume":"17","author":"Biglia","year":"2017","journal-title":"Clin. Breast Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3390\/jpm5020050","article-title":"Atrophic Vaginitis in Breast Cancer Survivors: A Difficult Survivorship Issue","volume":"5","author":"Lester","year":"2015","journal-title":"J. Pers. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/GME.0000000000000329","article-title":"Genitourinary Syndrome of Menopause: New Terminology for Vulvovaginal Atrophy from the International Society for the Study of Women\u2019s Sexual Health and the North American Menopause Society","volume":"21","author":"Portman","year":"2014","journal-title":"Menopause"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Merlino, L., D\u2019Ovidio, G., Matys, V., Piccioni, M.G., Porpora, M.G., Senatori, R., Viscardi, M.F., Vitale, A., and Della Rocca, C. (2023). Therapeutic Choices for Genitourinary Syndrome of Menopause (GSM) in Breast Cancer Survivors: A Systematic Review and Update. Pharmaceuticals, 16.","DOI":"10.3390\/ph16040550"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1610383","DOI":"10.3389\/pore.2022.1610383","article-title":"Systemic Treatment of Breast Cancer. 1st Central-Eastern European Professional Consensus Statement on Breast Cancer","volume":"28","author":"Rubovszky","year":"2022","journal-title":"Pathol. Oncol. Res."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Wang, Y., Li, Y., Liang, J., Zhang, N., and Yang, Q. (2022). Chemotherapy-Induced Amenorrhea and Its Prognostic Significance in Premenopausal Women with Breast Cancer: An Updated Meta-Analysis. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.859974"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/0284186X.2016.1275778","article-title":"Radiotherapy-Induced Vaginal Fibrosis in Cervical Cancer Survivors","volume":"56","author":"Blomgren","year":"2017","journal-title":"Acta Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00192-021-04798-8","article-title":"Vaginal Stenosis in Women with Cervical or Endometrial Cancer after Pelvic Radiotherapy: A Cross-Sectional Study of Vaginal Measurements, Risk for Sexual Dysfunction and Quality of Life","volume":"33","author":"Derchain","year":"2022","journal-title":"Int. Urogynecol. J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"26.e1","DOI":"10.1016\/j.ajog.2010.08.035","article-title":"Urogenital Disorders in Women with Adjuvant Endocrine Therapy after Early Breast Cancer","volume":"204","author":"Baumgart","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1097\/GME.0000000000000926","article-title":"Missing Documentation in Breast Cancer Survivors: Genitourinary Syndrome of Menopause","volume":"24","author":"Cook","year":"2017","journal-title":"Menopause"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"S383","DOI":"10.1016\/j.jsxm.2018.04.573","article-title":"665 Prevalence of Vaginal Stenosis in the Physical Therapy Evaluation after High Dose Rate Brachytherapy at a Referral Center in Southern Brazil","volume":"15","author":"Dias","year":"2018","journal-title":"J. Sex. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/ijgc-00009577-200601000-00046","article-title":"Vaginal Stenosis in Patients Treated with Radiotherapy for Carcinoma of the Cervix","volume":"16","author":"Brand","year":"2006","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s12282-021-01260-x","article-title":"Genitourinary Symptoms in Women with Breast Cancer: What Do Oncology Health Professionals Think and Do about Them?","volume":"28","author":"Pearson","year":"2021","journal-title":"Breast Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000496036","article-title":"Clinical Evaluation of Low-Molecular-Weight Hyaluronic Acid-Based Treatment on Onset of Acute Side Effects in Women Receiving Adjuvant Radiotherapy after Cervical Surgery: A Randomized Clinical Trial","volume":"42","author":"Delia","year":"2019","journal-title":"Oncol. Res. Treat."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Nappi, R.E., Martella, S., Albani, F., Cassani, C., Martini, E., and Landoni, F. (2022). Hyaluronic Acid: A Valid Therapeutic Option for Early Management of Genitourinary Syndrome of Menopause in Cancer Survivors?. Healthcare, 10.","DOI":"10.3390\/healthcare10081528"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00404-024-07552-9","article-title":"The Effects of Various Therapies on Vulvovaginal Atrophy and Quality of Life in Gynecological Cancer Patients: A Systematic Review","volume":"310","author":"Medeiros","year":"2024","journal-title":"Arch. Gynecol. Obs."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"338","DOI":"10.17749\/2313-7347\/ob.gyn.rep.2024.537","article-title":"The impact of rehabilitation on the quality of life of patients with vulvovaginal atrophy","volume":"18","author":"Ampilogova","year":"2024","journal-title":"Obstet. Gynecol. Reprod."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"The NAMS 2020 GSM Position Statement Editorial Panel (2020). The 2020 Genitourinary Syndrome of Menopause Position Statement of the North American Menopause Society. Menopause, 27, 976\u2013992.","DOI":"10.1097\/GME.0000000000001609"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Advisory Panel (2022). The 2022 Hormone Therapy Position Statement of the North American Menopause Society. Menopause, 29, 767\u2013794.","DOI":"10.1097\/GME.0000000000002028"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/13697137.2023.2190508","article-title":"Satisfaction and Medication Adherence in Women with Vulvovaginal Atrophy: The CRETA","volume":"26","author":"Palacios","year":"2023","journal-title":"Climacteric"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"107950","DOI":"10.1016\/j.maturitas.2024.107950","article-title":"Vulvovaginal Atrophy in Women with and without a History of Breast Cancer: Baseline Data from the Patient Satisfaction Study (PEONY) in Italy","volume":"183","author":"Meriggiola","year":"2024","journal-title":"Maturitas"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Stuopelyt\u0117, R., \u017dukien\u0117, G., Breivien\u0117, R., Rudaitis, V., and Bartkevi\u010dien\u0117, D. (2023). Quality of Life in Cervical Cancer Survivors Treated with Concurrent Chemoradiotherapy. Medicina, 59.","DOI":"10.3390\/medicina59040777"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1080\/13697137.2019.1600499","article-title":"Assessing Symptomatic Vulvar, Vaginal, and Lower Urinary Tract Atrophy","volume":"22","author":"Palacios","year":"2019","journal-title":"Climacteric"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/13697137.2018.1529748","article-title":"Vaginal Atrophy across the Menopausal Age: Results from the ANGEL Study","volume":"22","author":"Cagnacci","year":"2019","journal-title":"Climacteric"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.maturitas.2015.09.001","article-title":"Vaginal Atrophy of Women in Postmenopause. Results from a Multicentric Observational Study: The AGATA Study","volume":"83","author":"Palma","year":"2016","journal-title":"Maturitas"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1080\/13697137.2018.1446930","article-title":"The European Vulvovaginal Epidemiological Survey (EVES): Prevalence, Symptoms and Impact of Vulvovaginal Atrophy of Menopause","volume":"21","author":"Palacios","year":"2018","journal-title":"Climacteric"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0378-5122(03)00087-2","article-title":"Menopause after Breast Cancer: A Survey on Breast Cancer Survivors","volume":"45","author":"Biglia","year":"2003","journal-title":"Maturitas"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Alvisi, S., Gava, G., Orsili, I., Giacomelli, G., Baldassarre, M., Seracchioli, R., and Meriggiola, M.C. (2019). Vaginal Health in Menopausal Women. Medicina, 55.","DOI":"10.3390\/medicina55100615"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Martins, J., Vaz, A.F., Grion, R.C., Costa-Paiva, L., and Baccaro, L.F. (2021). Topical Estrogen, Testosterone, and Vaginal Dilator in the Prevention of Vaginal Stenosis after Radiotherapy in Women with Cervical Cancer: A Randomized Clinical Trial. BMC Cancer, 21.","DOI":"10.1186\/s12885-021-08274-w"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s10549-021-06226-3","article-title":"Effects of Local Laser Treatment on Vulvovaginal Atrophy among Women with Breast Cancer: A Prospective Study with Long-Term Follow-Up","volume":"188","author":"Veron","year":"2021","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1097\/GME.0000000000001350","article-title":"Effects of Ospemifene on Genitourinary Health Assessed by Prospective Vulvar-Vestibular Photography and Vaginal\/Vulvar Health Indices","volume":"26","author":"Goldstein","year":"2019","journal-title":"Menopause"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/13697137.2016.1258396","article-title":"Can Polyacrylic Acid Treat Sexual Dysfunction in Women with Breast Cancer Receiving Tamoxifen?","volume":"20","author":"Juliato","year":"2017","journal-title":"Climacteric"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Garcia de Arriba, S., Gr\u00fcntkemeier, L., H\u00e4user, M., May, T.W., Masur, C., and Stute, P. (2022). Vaginal Hormone-Free Moisturising Cream Is Not Inferior to an Estriol Cream for Treating Symptoms of Vulvovaginal Atrophy: Prospective, Randomised Study. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0266633"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ejogrb.2022.01.021","article-title":"Polycarbophil Vaginal Moisturizing Gel versus Hyaluronic Acid Gel in Women Affected by Vaginal Dryness in Late Menopausal Transition: A Prospective Randomized Trial","volume":"270","author":"Cagnacci","year":"2022","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"113760","DOI":"10.1016\/j.jep.2020.113760","article-title":"Aloe Vera; A New Treatment for Atrophic Vaginitis, A Randomized Double-Blinded Controlled Trial","volume":"270","author":"Poordast","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.jsxm.2022.03.536","article-title":"Effect of Chamomile Vaginal Gel on the Sexual Function in Postmenopausal Women: A Double-Blind Randomized Controlled Trial","volume":"19","author":"Bosak","year":"2022","journal-title":"J. Sex. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s00520-019-04684-6","article-title":"The Effect of Vitamin D and E Vaginal Suppositories on Tamoxifen-Induced Vaginal Atrophy in Women with Breast Cancer","volume":"27","author":"Keshavarzi","year":"2019","journal-title":"Support. Care Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Kamronrithisorn, T., Manonai, J., Vallibhakara, S.A.-O., Sophonsritsuk, A., and Vallibhakara, O. (2020). Effect of Vitamin D Supplement on Vulvovaginal Atrophy of the Menopause. Nutrients, 12.","DOI":"10.3390\/nu12092876"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.maturitas.2022.01.005","article-title":"Effects of Pueraria Mirifica on Vaginal Artery Vascularization in Postmenopausal Women with Genitourinary Syndrome of Menopause","volume":"160","author":"Warinsiriruk","year":"2022","journal-title":"Maturitas"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/13697137.2020.1752172","article-title":"Glycine Max (L.) Merr Isoflavone Gel Improves Vaginal Vascularization in Postmenopausal Women","volume":"23","author":"Lima","year":"2020","journal-title":"Climacteric"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.maturitas.2020.06.005","article-title":"Comparison of the Effects of Pueraria mirifica Gel and of Placebo Gel on the Vaginal Microenvironment of Postmenopausal Women with Genitourinary Syndrome of Menopause (GSM)","volume":"140","author":"Sritonchai","year":"2020","journal-title":"Maturitas"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1159\/000514944","article-title":"The Effect of Panax Ginseng on Genitourinary Syndrome in Postmenopausal Women: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial","volume":"28","author":"Ghorbani","year":"2021","journal-title":"Complement. Med. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"100116","DOI":"10.1016\/j.clinsp.2022.100116","article-title":"Effects of Oxytocin versus Promestriene on Genitourinary Syndrome: A Pilot, Prospective, Randomized, Double-Blind Study","volume":"77","author":"Santos","year":"2022","journal-title":"Clinics"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/0092623X.2020.1738606","article-title":"The Impact of Oxytocin Vaginal Gel on Sexual Function in Postmenopausal Women: A Randomized Controlled Trial","volume":"46","author":"Abedi","year":"2020","journal-title":"J. Sex Marital Ther."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/13697137.2023.2211763","article-title":"Pharmacokinetics, Safety and Preliminary Pharmacodynamic Evaluation of DARE-VVA1: A Soft Gelatin Capsule Containing Tamoxifen for the Treatment of Vulvovaginal Atrophy","volume":"26","author":"Thurman","year":"2023","journal-title":"Climacteric"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1007\/s00266-023-03550-5","article-title":"Injection Treatments for Vulvovaginal Atrophy of Menopause: A Systematic Review","volume":"47","author":"Moccia","year":"2023","journal-title":"Aesthetic Plast. Surg."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4269","DOI":"10.1111\/jocd.14873","article-title":"Clinical Evaluation of Autologous Platelet Rich Plasma Injection in Postmenopausal Vulvovaginal Atrophy: A Pilot Study","volume":"21","author":"Saleh","year":"2022","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1097\/GME.0000000000001122","article-title":"Efficacy of Injecting Platelet Concentrate Combined with Hyaluronic Acid for the Treatment of Vulvovaginal Atrophy in Postmenopausal Women with History of Breast Cancer: A Phase 2 Pilot Study","volume":"25","author":"Hersant","year":"2018","journal-title":"Menopause"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Berreni, N., Salerno, J., Chevalier, T., Alonso, S., and Mares, P. (2021). Evaluation of the Effect of Multipoint Intra-Mucosal Vaginal Injection of a Specific Cross-Linked Hyaluronic Acid for Vulvovaginal Atrophy: A Prospective Bi-Centric Pilot Study. BMC Women\u2019s Health, 21.","DOI":"10.1186\/s12905-021-01435-w"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.brachy.2020.08.021","article-title":"Configuration Analysis of the Injection Position and Shape of the Gel Spacer in Gynecologic Brachytherapy","volume":"20","author":"Iijima","year":"2021","journal-title":"Brachytherapy"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jsbmb.2016.03.016","article-title":"Serum Steroid Concentrations Remain within Normal Postmenopausal Values in Women Receiving Daily 6.5 Mg Intravaginal Prasterone for 12 Weeks","volume":"159","author":"Martel","year":"2016","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/09513590.2020.1757058","article-title":"Ospemifene Efficacy and Safety Data in Women with Vulvovaginal Atrophy","volume":"36","author":"Pup","year":"2020","journal-title":"Gynecol. Endocrinol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.maturitas.2018.11.017","article-title":"Ospemifene for the Treatment of Vulvar and Vaginal Atrophy: A Meta-Analysis of Randomized Trials. Part II: Evaluation of Tolerability and Safety","volume":"121","author":"Schiavi","year":"2019","journal-title":"Maturitas"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e731","DOI":"10.1016\/j.clbc.2019.07.007","article-title":"The Safety of Local Hormonal Treatment for Vulvovaginal Atrophy in Women with Estrogen Receptor-Positive Breast Cancer Who Are on Adjuvant Aromatase Inhibitor Therapy: Meta-Analysis","volume":"19","author":"Mamillapalli","year":"2019","journal-title":"Clin. Breast Cancer"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e1846","DOI":"10.1634\/theoncologist.2020-0417","article-title":"A Phase II Prospective, Randomized, Double-Blind, Placebo-Controlled and Multicenter Clinical Trial to Assess the Safety of 0.005% Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women with Early Stage Breast Cancer in Treatment with Aromatase Inhibitor in the Adjuvant Setting","volume":"25","author":"Hirschberg","year":"2020","journal-title":"Oncologist"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10549-012-2198-y","article-title":"Local Estrogen Therapy and Risk of Breast Cancer Recurrence among Hormone-Treated Patients: A Nested Case\u2013Control Study","volume":"135","author":"Bonnetain","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1080\/0284186X.2017.1400684","article-title":"Radiotherapy for Cervical Cancer\u2014Impact on the Vaginal Epithelium and Sexual Function","volume":"57","author":"Bergmark","year":"2018","journal-title":"Acta Oncol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s00520-018-4441-5","article-title":"Extended Duration of Dilator Use beyond 1 Year May Reduce Vaginal Stenosis after Intravaginal High-Dose-Rate Brachytherapy","volume":"27","author":"Stahl","year":"2019","journal-title":"Support. Care Cancer"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.maturitas.2019.03.002","article-title":"Pelvic Floor Muscle Training as a Treatment for Genitourinary Syndrome of Menopause: A Single-Arm Feasibility Study","volume":"125","author":"Mercier","year":"2019","journal-title":"Maturitas"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e2255697","DOI":"10.1001\/jamanetworkopen.2022.55697","article-title":"Effect of Fractional Carbon Dioxide vs Sham Laser on Sexual Function in Survivors of Breast Cancer Receiving Aromatase Inhibitors for Genitourinary Syndrome of Menopause","volume":"6","author":"Mension","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.maturitas.2022.08.013","article-title":"Vaginal Laser Therapy versus Hyaluronic Acid Suppositories for Women with Symptoms of Urogenital Atrophy after Treatment for Breast Cancer: A Randomized Controlled Trial","volume":"167","author":"Gold","year":"2023","journal-title":"Maturitas"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1097\/GME.0000000000002274","article-title":"CO2 Laser, Radiofrequency, and Promestriene in the Treatment of Genitourinary Syndrome of Menopause in Breast Cancer Survivors: A Histomorphometric Evaluation of the Vulvar Vestibule","volume":"30","author":"Fernandes","year":"2023","journal-title":"Menopause"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.maturitas.2020.10.018","article-title":"Pilot Study of Fractional CO2 Laser Therapy for Genitourinary Syndrome of Menopause in Gynecologic Cancer Survivors","volume":"144","author":"Quick","year":"2021","journal-title":"Maturitas"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/GME.0000000000002118","article-title":"Superficial Dyspareunia Treatment with Hyperstacking of Erbium:Yttrium-Aluminum-Garnet SMOOTH Laser: A Short-Term, Pilot Study in Breast Cancer Survivors","volume":"30","author":"Fidecicchi","year":"2023","journal-title":"Menopause"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/GME.0000000000001333","article-title":"Fractional CO2 Laser versus Promestriene and Lubricant in Genitourinary Syndrome of Menopause: A Randomized Clinical Trial","volume":"26","author":"Politano","year":"2019","journal-title":"Menopause"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/1471-0528.17335","article-title":"Laser versus Sham for Genitourinary Syndrome of Menopause: A Randomised Controlled Trial","volume":"130","author":"Page","year":"2023","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/13697137.2020.1829584","article-title":"CO2 Laser and the Genitourinary Syndrome of Menopause: A Randomized Sham-Controlled Trial","volume":"24","author":"Salvatore","year":"2021","journal-title":"Climacteric"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"278.e1","DOI":"10.1016\/j.ajog.2023.05.005","article-title":"Vaginal Epithelial Histology before and after Fractional CO2 Laser in Postmenopausal Women: A Double-Blind, Sham-Controlled Randomized Trial","volume":"229","author":"Li","year":"2023","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jsxm.2021.01.188","article-title":"A Double-Blind Randomized Sham-Controlled Trial to Evaluate the Efficacy of Fractional Carbon Dioxide Laser Therapy on Genitourinary Syndrome of Menopause","volume":"18","author":"Cruff","year":"2021","journal-title":"J. Sex. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/GME.0000000000001416","article-title":"A Randomized Clinical Trial Comparing Vaginal Laser Therapy to Vaginal Estrogen Therapy in Women with Genitourinary Syndrome of Menopause: The VeLVET Trial","volume":"27","author":"Paraiso","year":"2020","journal-title":"Menopause"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"100293","DOI":"10.1016\/j.clinsp.2023.100293","article-title":"Microablative Fractional Radiofrequency for Sexual Dysfunction and Vaginal Trophism: A Randomized Clinical Trial","volume":"78","author":"Sarmento","year":"2023","journal-title":"Clinics"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Kolczewski, P., Parafiniuk, M., Zawodny, P., Haddad, R., Nalewczy\u0144ska, A., Kolasa, A.K., Wiszniewska, B., Menkes, S., Bader, A., and Stabile, G. (2022). Hyaluronic Acid and Radiofrequency in Patients with Urogenital Atrophy and Vaginal Laxity. Pharmaceuticals, 15.","DOI":"10.3390\/ph15121571"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/10\/1584\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:04:33Z","timestamp":1760112273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/10\/1584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":73,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["medicina60101584"],"URL":"https:\/\/doi.org\/10.3390\/medicina60101584","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,27]]}}}